Zoetis Inc - Ordinary Shares - Class A
NYSE:ZTS
| Market Cap (Intraday) | 97.05B |
| Current PE | 50.92 |
| Forward PE | 44.9 |
| 2yr Forward PE | 39.76 |
| 10-Day MA | $203.16 |
| 50-Day MA | $203.36 |
| 200-Day MA | $176.33 |
Zoetis Inc - Ordinary Shares - Class A Stock, NYSE:ZTS
10 Sylvan Way, 10 Sylvan Way, Parsippany, New Jersey 07054
Phone: +1.973.822.7000
Number of Employees: 11300
Description
Zoetis, Inc. discovers, develops, and manufactures a portfolio of animal health medicines and vaccines. The firm operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices, and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.